Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 369179, 7 pages
http://dx.doi.org/10.1155/2015/369179
Research Article

Association between Hyperuricemia and Metabolic Syndrome: An Epidemiological Study of a Labor Force Population in Taiwan

1Department of Neurology, Show Chwan Memorial Hospital, Changhua County 50008, Taiwan
2Department of Neurology, Chang Bing Show Chwan Memorial Hospital, Changhua County 50544, Taiwan
3Department of Exercise and Health Promotion, College of Education, Chinese Culture University, Taipei City 11114, Taiwan
4Physical Examination Center, Show Chwan Memorial Hospital, Changhua County 50008, Taiwan
5Division of Allergy, Immunology and Rheumatology, Chung Shan Medical University, Taichung City 40201, Taiwan
6Department of Public Health, College of Medicine, Fu-Jen Catholic University, New Taipei City 24205, Taiwan
7Sleep Center, Chang Bing Show-Chwan Memorial Hospital, Changhua County 50544, Taiwan
8School of Public Health, National Defense Medical Center, Taipei City 11490, Taiwan
9Department of Nursing, Meiho University, Pingtung County 91202, Taiwan
10Department of Health Business Administration, Meiho University, Pingtung County 91202, Taiwan

Received 12 June 2014; Accepted 26 November 2014

Academic Editor: Yi Liu

Copyright © 2015 Cheng-Yu Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. D. Bieber and R. A. Terkeltaub, “Gout: on the brink of novel therapeutic options for an ancient disease,” Arthritis and Rheumatism, vol. 50, no. 8, pp. 2400–2414, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. P. Richette and T. Bardin, “Gout,” The Lancet, vol. 375, no. 9711, pp. 318–328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. H. K. Choi, E. S. Ford, C. Li, and G. Curhan, “Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey,” Arthritis Care and Research, vol. 57, no. 1, pp. 109–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. H. G. Yoo, S. I. Lee, H. J. Chae, S. J. Park, Y. C. Lee, and W. H. Yoo, “Prevalence of insulin resistance and metabolic syndrome in patients with gouty arthritis,” Rheumatology International, vol. 31, no. 4, pp. 485–491, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Vázquez-Mellado, C. García García, S. Guzmán Vázquez et al., “Metabolic syndrome and ischemic heart disease in gout,” Journal of Clinical Rheumatology, vol. 10, no. 3, pp. 105–109, 2004. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. H. Rho, S. J. Choi, Y. H. Lee et al., “The prevalence of metabolic syndrome in patients with gout: a multicenter study,” Journal of Korean Medical Science, vol. 20, no. 6, pp. 1029–1033, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. W.-Y. Lee, J.-S. Park, S.-Y. Noh, E.-J. Rhee, S.-W. Kim, and P. Z. Zimmet, “Prevalence of the metabolic syndrome among 40,698 Korean metropolitan subjects,” Diabetes Research and Clinical Practice, vol. 65, no. 2, pp. 143–149, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. H. Rho, S. J. Choi, Y. H. Lee et al., “Prevalence of the metabolic syndrome in patients with gout,” The Journal of the Korean Rheumatism Association, vol. 11, pp. 349–357, 2004. View at Google Scholar
  9. B. Emmerson, “Hyperlipidaemia in hyperuricaemia and gout,” Annals of the Rheumatic Diseases, vol. 57, no. 9, pp. 509–510, 1998. View at Publisher · View at Google Scholar · View at Scopus
  10. A. G. Fam, “Gout, diet, and the insulin resistance syndrome,” Journal of Rheumatology, vol. 29, no. 7, pp. 1350–1355, 2002. View at Google Scholar · View at Scopus
  11. H. K. Choi, D. B. Mount, and A. M. Reginato, “Pathogenesis of gout,” Annals of Internal Medicine, vol. 143, no. 7, pp. 499–516, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. R. H. Eckel, K. Alberti, S. M. Grundy, and P. Z. Zimmet, “The metabolic syndrome,” The Lancet, vol. 375, no. 9710, pp. 181–183, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. L. C. Hwang and K. C. Huang, “Definition and epidemiology of metabolic syndrome,” Formosan Journal of Medicine, vol. 11, pp. 363–369, 2007. View at Google Scholar
  14. P. W. F. Wilson, R. B. D'Agostino, H. Parise, L. Sullivan, and J. B. Meigs, “Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus,” Circulation, vol. 112, no. 20, pp. 3066–3072, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. E. S. Ford, W. H. Giles, and A. H. Mokdad, “Increasing prevalence of the metabolic syndrome among U.S. adults,” Diabetes Care, vol. 27, no. 10, pp. 2444–2449, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. L.-C. Hwang, C.-H. Bai, and C.-J. Chen, “Prevalence of obesity and metabolic syndrome in Taiwan,” Journal of the Formosan Medical Association, vol. 105, no. 8, pp. 626–635, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Reimann, A. E. Schutte, L. Malan, H. W. Huisman, and N. T. Malan, “Hyperuricaemia is an independent factor for the metabolic syndrome in a sub-Saharan African population: a factor analysis,” Atherosclerosis, vol. 197, no. 2, pp. 638–645, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. P.-W. Liu, T.-Y. Chang, and J.-D. Chen, “Serum uric acid and metabolic syndrome in Taiwanese adults,” Metabolism: Clinical and Experimental, vol. 59, no. 6, pp. 802–807, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C.-S. Lin, Y.-J. Hung, G.-Y. Chen et al., “A multicenter study of the association of serum uric acid, serum creatinine, and diuretic use in hypertensive patients,” International Journal of Cardiology, vol. 148, no. 3, pp. 325–330, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Sonoda, H. Takase, Y. Dohi, and G. Kimura, “Uric acid levels predict future development of chronic kidney disease,” The American Journal of Nephrology, vol. 33, no. 4, pp. 352–357, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. R. P. Obermayr, C. Temml, G. Gutjahr, M. Knechtelsdorfer, R. Oberbauer, and R. Klauser-Braun, “Elevated uric acid increases the risk for kidney disease,” Journal of the American Society of Nephrology, vol. 19, no. 12, pp. 2407–2413, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. H.-Y. Chang, C.-W. Tung, P.-H. Lee et al., “Hyperuricemia as an independent risk factor of chronic kidney disease in middle-aged and elderly population,” American Journal of the Medical Sciences, vol. 339, no. 6, pp. 509–515, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. J. I. Cleeman, “Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III),” The Journal of the American Medical Association, vol. 285, no. 19, pp. 2486–2497, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. E. Tan, S. Ma, D. Wai, S. K. Chew, and E. S. Tai, “Can we apply the National Cholesterol Education Program adult treatment panel definition of the metabolic syndrome to Asians?” Diabetes Care, vol. 27, no. 5, pp. 1182–1186, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. R. Kawamoto, H. Tomita, Y. Oka, A. Kodama, and A. Kamitani, “Metabolic syndrome amplifies the LDL-cholesterol associated increases in carotid atherosclerosis,” Internal Medicine, vol. 44, no. 12, pp. 1232–1238, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. R. J. Johnson, D.-H. Kang, D. Feig et al., “Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?” Hypertension, vol. 41, no. 6, pp. 1183–1190, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K.-L. Chien, M.-F. Chen, H.-C. Hsu et al., “Plasma uric acid and the risk of type 2 diabetes in a Chinese community,” Clinical Chemistry, vol. 54, no. 2, pp. 310–316, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. X. Sui, T. S. Church, R. A. Meriwether, F. Lobelo, and S. N. Blair, “Uric acid and the development of metabolic syndrome in women and men,” Metabolism: Clinical and Experimental, vol. 57, no. 6, pp. 845–852, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-H. Chen, S.-Y. Chuang, H.-J. Chen, Y. E. H. Wen-Ting, and P. A. N. Wen-Harn, “Serum uric acid level as an independent risk factor for all-cause, cardiovascular, and ischemic stroke mortality: a chinese cohort study,” Arthritis Care and Research, vol. 61, no. 2, pp. 225–232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. C. Hawang, C. H. Bai, C. J. Chen, and K. L. Chien, “Gender different on the development of metabolic syndrome: a population-based study in Taiwan,” European Journal of Epidemiology, vol. 22, pp. 2486–2497, 2007. View at Google Scholar
  31. B. Balkau, M. Vernay, L. Mhamdi et al., “The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study,” Diabetes and Metabolism, vol. 29, no. 5, pp. 526–532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. G. Hu, Q. Qiao, J. Tuomilehto, B. Balkau, K. Borch-Johnsen, and K. Pyorala, “Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women,” Archives of Internal Medicine, vol. 164, no. 10, pp. 1066–1076, 2004. View at Publisher · View at Google Scholar · View at Scopus
  33. S.-Y. Chuang, C.-H. Chen, and P. Chou, “Prevalence of metabolic syndrome in a large health check-up population in Taiwan,” Journal of the Chinese Medical Association, vol. 67, no. 12, pp. 611–620, 2004. View at Google Scholar · View at Scopus
  34. Y. C. Yang and C. J. Chang, “Metabolic syndrome, obesity and diabetes,” Formosan Journal of Medicine, vol. 11, pp. 370–380, 2007. View at Google Scholar
  35. J. Fang and M. H. Alderman, “Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992,” Journal of the American Medical Association, vol. 283, no. 18, pp. 2404–2410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. P. B. Mellen, A. J. Bleyer, T. P. Erlinger et al., “Serum uric acid predicts incident hypertension in a biethnic cohort: the Atherosclerosis Risk in Communities study,” Hypertension, vol. 48, no. 6, pp. 1037–1042, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. E. S. Ford, C. Li, S. Cook, and H. K. Choi, “Serum concentrations of uric acid and the metabolic syndrome among US children and adolescents,” Circulation, vol. 115, no. 19, pp. 2526–2532, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. L.-K. Chen, M.-H. Lin, H.-Y. Lai, S.-J. Hwang, and S.-T. Chiou, “Uric acid: a surrogate of insulin resistance in older women,” Maturitas, vol. 59, no. 1, pp. 55–61, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. M. S. Lee, S. C. Lin, H. Y. Chang, L. C. Lyu, K. S. Tsai, and W. H. Pan, “High prevalence of hyperuricemia in elderly Taiwanese,” Asia Pacific Journal of Clinical Nutrition, vol. 14, no. 3, pp. 285–292, 2005. View at Google Scholar · View at Scopus
  40. T. Nakagawa, D.-H. Kang, D. Feig et al., “Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease,” Kidney International, vol. 69, no. 10, pp. 1722–1725, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. D. B. Corry, P. Eslami, K. Yamamoto, M. D. Nyby, H. Makino, and M. L. Tuck, “Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system,” Journal of Hypertension, vol. 26, no. 2, pp. 269–275, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Facchini, Y.-D. I. Chen, C. B. Hollenbeck, and G. M. Reaven, “Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration,” The Journal of the American Medical Association, vol. 266, no. 21, pp. 3008–3011, 1991. View at Publisher · View at Google Scholar · View at Scopus